Chapter 21: Tobacco
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Tobacco Labelling -.:: GEOCITIES.Ws
Council Directive 89/622/EC concerning the labelling of tobacco products, as amended TAR AND NICOTINE CONTENTS OF THE CIGARETTES SOLD ON THE EUROPEAN MARKET AUSTRIA Brand Tar Yield Nicotine Yield Mg. Mg. List 1 A3 14.0 0.8 A3 Filter 11.0 0.6 Belvedere 11.0 0.8 Camel Filters 14.0 1.1 Camel Filters 100 13.0 1.1 Camel Lights 8.0 0.7 Casablanca 6.0 0.6 Casablanca Ultra 2.0 0.2 Corso 4.0 0.4 Da Capo 9.0 0.4 Dames 9.0 0.6 Dames Filter Box 9.0 0.6 Ernte 23 13.0 0.8 Falk 5.0 0.4 Flirt 14.0 0.9 Flirt Filter 11.0 0.6 Golden Smart 12.0 0.8 HB 13.0 0.9 HB 100 14.0 1.0 Hobby 11.0 0.8 Hobby Box 11.0 0.8 Hobby Extra 11.0 0.8 Johnny Filter 11.0 0.9 Jonny 14.0 1.0 Kent 10.0 0.8 Kim 8.0 0.6 Kim Superlights 4.0 0.4 Lord Extra 8.0 0.6 Lucky Strike 13.0 1.0 Lucky Strike Lights 9.0 0.7 Marlboro 13.0 0.9 Marlboro 100 14.0 1.0 Marlboro Lights 7.0 0.6 Malboro Medium 9.0 0.7 Maverick 11.0 0.8 Memphis Classic 11.0 0.8 Memphis Blue 12.0 0.8 Memphis International 13.0 1.0 Memphis International 100 14.0 1.0 Memphis Lights 7.0 0.6 Memphis Lights 100 9.0 0.7 Memphis Medium 9.0 0.6 Memphis Menthol 7.0 0.5 Men 11.0 0.9 Men Light 5.0 0.5 Milde Sorte 8.0 0.5 Milde Sorte 1 1.0 0.1 Milde Sorte 100 9.0 0.5 Milde Sorte Super 6.0 0.3 Milde Sorte Ultra 4.0 0.4 Parisienne Mild 8.0 0.7 Parisienne Super 11.0 0.9 Peter Stuyvesant 12.0 0.8 Philip Morris Super Lights 4.0 0.4 Ronson 13.0 1.1 Smart Export 10.0 0.8 Treff 14.0 0.9 Trend 5.0 0.2 Trussardi Light 100 6.0 0.5 United E 12.0 0.9 Winston 13.0 0.9 York 9.0 0.7 List 2 Auslese de luxe 1.0 0.1 Benson & Hedges 12.0 1.0 Camel 15.0 1.0 -
Youth Bidi, Kretek, Or Pipe Tobacco Use
2013 Florida Youth Tobacco Survey: Fact Sheet 10 Youth Bidi, Kretek, or Pipe Tobacco Use Introduction The Florida Youth Tobacco Survey (FYTS) was administered in the spring of 2013 to 6,440 middle school students and 6,175 high school students in 172 public schools throughout the state. The overall survey response rate for middle schools was 83%, and the overall survey response rate for high schools was 75%. The FYTS has been conduct- ed annually since 1998. The data presented in this fact sheet are weighted to represent the entire population of public middle and high school students in Florida. About Bidis, Kreteks, and Pipe Tobacco Bidis are small brown cigarettes from India consisting of tobacco wrapped in a leaf tied together with a thread. Bidis have higher levels of nicotine, carbon monoxide, and tar than traditional cigarettes. Kreteks are cigarettes containing tobacco and clove extract. In 2009, the Food and Drug Administration banned kreteks, along with flavored cigarettes, from being sold in the United States. Pipe tobacco comes either plain or flavored and is smoked through a pipe. On previous FYTS fact sheets, bidis, kreteks, and pipe tobacco have been Figure 1. Ever Tried Bidis, Kreteks, or Pipe Tobacco 8.4 8.5 reported as “specialty tobacco” products. 9 8.0 8 7.2 7.1 Ever Tried Bidis, Kreteks, or Pipe Tobacco 7 5.9 6 In 2013, 2.5% of middle school and 5.9% of high 5 4 3.2 school students had tried smoking a bidi, kretek, or Percent 2.9 3.0 3.0 2.5 2.5 pipe tobacco at least once (Figure 1). -
Roc Background Document: Tobacco Smoking
FINAL Report on Carcinogens Background Document for Environmental Tobacco Smoke December 2 - 3, 1998 Meeting of the NTP Board of Scientific Counselors Report on Carcinogens Subcommittee Prepared for the: U.S. Department of Health and Human Services Public Health Services National Toxicology Program Research Triangle Park, North Carolina 27709 Prepared by: Technology Planning and Management Corporation Canterbury Hall, Suite 310 4815 Emperor Boulevard Durham, NC 27703 Contract Number NOI-ES-85421 RoC Background Document for Environmental Tobacco Smoke Table of Contents Summary Statement..................................................................................................................v 1 Physical and Chemical Properties ......................................................................................1 1.1 Chemical Identification...........................................................................................1 2 Human Exposure.................................................................................................................9 2.1 Biomarkers of Exposure..........................................................................................9 2.1.1 Nicotine and Cotinine...............................................................................9 2.1.2 Carbon Monoxide and Carboxyhemoglobin ...........................................10 2.1.3 Thioethers ..............................................................................................10 2.1.4 Thiocyanate............................................................................................10 -
Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender
Opioid and Nicotine: Influences of Sex and Gender Conference Report: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender Authors: Bridget M. Nugent, PhD. Staff Fellow, FDA OWH Emily Ayuso, MS. ORISE Fellow, FDA OWH Rebekah Zinn, PhD. Health Program Coordinator, FDA OWH Erin South, PharmD. Pharmacist, FDA OWH Cora Lee Wetherington, PhD. Women & Sex/Gender Differences Research Coordinator, NIH NIDA Sherry McKee, PhD. Professor, Psychiatry; Director, Yale Behavioral Pharmacology Laboratory Jill Becker, PhD. Biopsychology Area Chair, Patricia Y. Gurin Collegiate Professor of Psychology and Research Professor, Molecular and Behavioral Neuroscience Institute, University of Michigan Hendrée E. Jones, Professor, Department of Obstetrics and Gynecology; Executive Director, Horizons, University of North Carolina at Chapel Hill Marjorie Jenkins, MD, MEdHP, FACP. Director, Medical Initiatives and Scientific Engagement, FDA OWH Acknowledgements: We would like to acknowledge and extend our gratitude to the meeting’s speakers and panel moderators: Mitra Ahadpour, Kelly Barth, Jill Becker, Kathleen Brady, Tony Campbell, Marilyn Carroll, Janine Clayton, Wilson Compton, Terri Cornelison, Teresa Franklin, Maciej Goniewcz, Shelly Greenfield, Gioia Guerrieri, Scott Gottlieb, Marsha Henderson, RADM Denise Hinton, Marjorie Jenkins, Hendrée Jones, Brian King, George Koob, Christine Lee, Sherry McKee, Tamra Meyer, Jeffery Mogil, Ann Murphy, Christine Nguyen, Cheryl Oncken, Kenneth Perkins, Yvonne Prutzman, Mehmet Sofuoglu, Jack Stein, Michelle Tarver, Martin Teicher, Mishka Terplan, RADM Sylvia Trent-Adams, Rita Valentino, Brenna VanFrank, Nora Volkow, Cora Lee Wetherington, Scott Winiecki, Mitch Zeller. We would also like to thank those who helped us plan this program. Our Executive Steering Committee included Ami Bahde, Carolyn Dresler, Celia Winchell, Cora Lee Wetherington, Jessica Tytel, Marjorie Jenkins, Pamela Scott, Rita Valentino, Tamra Meyer, and Terri Cornelison. -
Technical Report Heated Tobacco Products
Heated Tobacco Products Task Force Technical Report Heated Tobacco Products (HTPs): Standardized Terminology and Recommendations for the Generation and Collection of Emissions July 2020 Author and Sub-Group Secretary: Jason Flora, Altria Client Services, U.S.A. Task-Force Coordinator: Helena Digard, British American Tobacco, U.K. Co-Author and Task Force Member: Colin Sinclair, Japan Tobacco Inc., U.K. Co-Author and Task Force Member: Maxim Belushkin, Philip Morris International, Switzerland Table of Contents 1. Introduction ....................................................................................................................... 3 2. Organisations .................................................................................................................... 3 2.1 Participants ................................................................................................................ 3 3. Definitions ........................................................................................................................ 4 3.1 Category Definition ................................................................................................... 5 3.2 Sub-Category Definitions .......................................................................................... 5 3.3 Additional Definitions ............................................................................................... 7 4. Recommendations for the Generation and Collection of Emissions ................................ 7 4.1 General Requirements .............................................................................................. -
Power Point Slides: Slide. One Slide for Long Term & Another for Short
Drug Research Project Drug Project Requirements: . Power Point Slides: Slide #1 - Introduction Slide #2 - Title page – Name of drug {technical and street names}, , & a picture of your drug or something that relates to your drug. Slide #3- The look – describe what your drug looks like in detail. Slide #4 - Information Page - Any background, history, statistics, or interesting facts Slide #7 Slide #8 - Drug Category {Narcotic, Depressant, Stimulant, Hallucinogen) AND DEFINE the category. Some drugs may fit into more than one category! Slide #9- Where does this drug come from {plant, lab, country} describe/explain Slide #10- Medical uses for your drug past & present. Slide #11- How is your drug used? {smoked, injected, sniffed, inhaled…} Slide #12- Long & Short term harmful effects of your drug. {Maybe more than one slide. One slide for long term & another for short term effects} Slide #13- Treatment – how can someone quit using the drug. – REHAB Slide #14- Conclusion about your drug how can we eliminate this drug? Slide #15- Site your sources of where you got your information from if taken from another website. Good site to start with: http://abovetheinfluence.com/drugs/alcohol/ TOPICS: 1. Heroin: ________________________________________________________ 2. Phencyclidine (PCP): _____________________________________________ 3. Alcohol: _______________________________________________________ 4. Smoking (cigarettes): _____________________________________________ 5. Smokeless Tobacco: ______________________________________________ -
Key Dates in Tobacco Regulation 1962 — 2020
Key dates in tobacco regulation 1962 — 2020 16 Further information about the early history of tobacco is available at: www.tobacco.org/History/history.html 1962 The first Royal College of Physicians (RCP) report, "Smoking and Health", was published. It received massive publicity. The main recommendations were: restriction of tobacco advertising; increased taxation on cigarettes; more restrictions on the sales of cigarettes to children, and smoking in public places; and more information on the tar/nicotine content of cigarettes. For the first time in a decade, cigarette sales fell. The Tobacco Advisory Committee (subsequently Council, and now known as the Tobacco Manufacturers’ Association) - which represents the interests of the tobacco industry - agreed to implement a code of advertising practice for cigarettes which was intended to take some of the glamour out of cigarette advertisements. The code was based on the former ITA code governing cigarette advertisements on TV (before they were removed in 1964, with the co-operation of the ITA) 1964 The US Surgeon General produced his first report on "Smoking and Health". Its conclusions corroborated those of the RCP and the US Surgeon General has produced annual reports since 1967 on the health consequences on smoking. Doll and Hill published the results of a nationwide prospective survey on "mortality in relation to smoking: 10 years' observations in British Doctors". Between 1951 and 1964 about half the UK's doctors who smoked gave up and there was a dramatic fall in lung cancer incidence among those who gave up as opposed to those who continued to smoke. 1965 After considerable debate, the government used the powers vested in it under the terms of the 1964 Television Act to ban cigarette advertisements on television. -
University of California San Francisco
UNIVERSITY OF CALIFORNIA SAN FRANCISCO BERKELEY • DAVIS • IRVINE • LOS ANGELES • MERCED • RIVERSIDE • SAN DIEGO • SAN FRANCISCO SANTA BARBARA • SANTA CRUZ STANTON A. GLANTZ, PhD 530 Parnassus Suite 366 Professor of Medicine (Cardiology) San Francisco, CA 94143-1390 Truth Initiative Distinguished Professor of Tobacco Control Phone: (415) 476-3893 Director, Center for Tobacco Control Research and Education Fax: (415) 514-9345 [email protected] December 20, 2017 Tobacco Products Scientific Advisory Committee c/o Caryn Cohen Office of Science Center for Tobacco Products Food and Drug Administration Document Control Center Bldg. 71, Rm. G335 10903 New Hampshire Ave. Silver Spring, MD 20993–0002 [email protected] Re: 82 FR 27487, Docket no. FDA-2017-D-3001-3002 for Modified Risk Tobacco Product Applications: Applications for IQOS System With Marlboro Heatsticks, IQOS System With Marlboro Smooth Menthol Heatsticks, and IQOS System With Marlboro Fresh Menthol Heatsticks Submitted by Philip Morris Products S.A.; Availability Dear Committee Members: We are submitting the 10 public comments that we have submitted to the above-referenced docket on Philip Morris’s modified risk tobacco product applications (MRTPA) for IQOS. It is barely a month before the meeting and the docket on IQOS has not even closed. As someone who has served and does serve on committees similar to TPSAC, I do not see how the schedule that the FDA has established for TPSAC’s consideration of this application can permit a responsible assessment of the applications and associated public comments. I sincerely hope that you will not be pressed to make any recommendations on the IQOS applications until the applications have been finalized, the public has had a reasonable time to assess the applications, and TPSAC has had a reasonable time to digest both the completed applications and the public comments before making any recommendation to the FDA. -
TAR WARS PROGRAM GUIDE Instructions for Implementing 2021-2022 School Year
TAR WARS PROGRAM GUIDE Instructions for Implementing 2021-2022 School Year Supported in part by a grant from the American Academy of Family Physicians Foundation. TABLE OF CONTENTS PAGE Introduction to Tar Wars ........................................2 Tips for Teachers .................................................3 Tips for Presenters ................................................4 Quick Guide for Presenters ..........................................5 Cigarettes Activity 1: What’s in a Cigarette? .......................................6 Activity 2: “Sticky Person” ...........................................7 Activity 3: Financial Impact ..........................................8 Activity 4: Effects on Breathing .......................................9 Activity 5: Lung Damage and Disease Risk from Smoke .................... 10 E-cigarettes, Vapes, and Other ENDS Activity 6: Electronic Cigarettes .....................................11-12 Activity 7: What is JUUL®? .......................................... 13 Activity 8: Vaping Fortune Teller ...................................... 14 Activity 9: Effects of Vaping on the Body .............................15-16 Other Tobacco Products Activity 10: Smokeless Flavored Tobacco Products ........................ 17 Activity 11: Flavored Cigars and Cigarillos ............................... 18 Activity 12: Hookah .............................................19-20 Big Tobacco - Selling Harmful Substances Activity 13: Power of Advertising ....................................21-22 Activity -
World Bank Document
HNP DISCUSSION PAPER Public Disclosure Authorized Public Disclosure Authorized Economics of Tobacco Control Paper No. 21 Research on Tobacco in China: About this series... An annotated bibliography of research on tobacco This series is produced by the Health, Nutrition, and Population Family (HNP) of the World Bank’s Human Development Network. The papers in this series aim to provide a vehicle for use, health effects, policies, farming and industry publishing preliminary and unpolished results on HNP topics to encourage discussion and Public Disclosure Authorized Public Disclosure Authorized debate. The findings, interpretations, and conclusions expressed in this paper are entirely those of the author(s) and should not be attributed in any manner to the World Bank, to its affiliated organizations or to members of its Board of Executive Directors or the countries they represent. Citation and the use of material presented in this series should take into account this provisional character. For free copies of papers in this series please contact the individual authors whose name appears on the paper. Joy de Beyer, Nina Kollars, Nancy Edwards, and Harold Cheung Enquiries about the series and submissions should be made directly to the Managing Editor Joy de Beyer ([email protected]) or HNP Advisory Service ([email protected], tel 202 473-2256, fax 202 522-3234). For more information, see also www.worldbank.org/hnppublications. The Economics of Tobacco Control sub-series is produced jointly with the Tobacco Free Initiative of the World Health Organization. The findings, interpretations and conclusions expressed in this paper are entirely those of the authors and should not be attributed in any Public Disclosure Authorized Public Disclosure Authorized manner to the World Health Organization or to the World Bank, their affiliated organizations or members of their Executive Boards or the countries they represent. -
Tobacco Harm Reduction
Tobacco Harm Reduction Brad Rodu Professor, Department of Medicine James Graham Brown Cancer Center University of Louisville The Smoking Status Quo: Unacceptable • The American Anti-Smoking Campaign is 45 Years Old • According to the CDC: 45 million smokers in the U.S. 443,000 deaths every year in the U.S. 5,800 in Oklahoma Lung Cancer (ICD 161-162) Mortality in Men and Women Age 35+, Oklahoma and the US, 1979-2009 250 OK Men 200 150 US Men OK Women 100 Deaths per 100,000 py 100,000 Deathsper US Women 50 0 Year If the Status Quo Continues In the next 20 years: • 8 million Americans will die from smoking All are adults over 35 years of age None of them are now children The Failed Anti-Smoking Campaign • The Campaign’s Only Message: Quit Nicotine and Tobacco, or Die • The Campaign’s Only Quitting Tactics: Ineffective Behavioral Therapy Ineffective Use of Nicotine Rodu and Cole. Technology 6: 17-21, 1999. Rodu and Cole. International J Cancer 97: 804-806, 2002. The Anti-Smoking Campaign- Behavioral Therapy • NCI Manual for Physicians- Counsel Patients to: – ”Keep your hands busy- doodle, knit, type a letter” – ”Cut a drinking straw into cigarette-sized pieces and inhale air” – ”Keep a daydream ready to go” Source: How to help your patients stop smoking. NIH Pub. No. 93-3064, 1993 The Anti-Smoking Campaign- Faulted Use of Nicotine • Temporary – 6 to 12 weeks • Expensive – per unit and per box • Very Low Dose – unsatisfying for smokers • 7% Success* – ”Efficacious”, ”Modest” *Hughes et al. Meta-analysis in Tobacco Control, 2003. -
Tobacco Fact Sheet What Is Smokeless Tobacco?
Tobacco Fact Sheet Smokeless Tobacco Keep Tobacco Sacred, Honor Your Health, Honor Your Nation Numbers What is Smokeless Tobacco? Smokeless tobacco products contain tobacco or tobacco blends that are ei- at a Glance ther chewed, sucked, or sniffed. Most smokeless tobacco products are placed 80% between the cheek or lips and gums for a few minutes to hours. They have many Higher risk of smokeless names, such as spit tobacco, chew, tobacco users developing oral pinch, or dip, and fall into several cate- cancer. gories. Chewing tobacco is in the form of loose 60% leaves, leaves pressed together that is commonly known as “plug,” to resem- Higher risk of smokeless ble a rope that is commonly known as tobacco users developing “twist.” Chewing tobacco is held be- pancreatic and esophageal tween the cheek and gum. Usually the tobacco juices are spit out, but long- cancer. Smokeless Tobacco is NOT a safe alternative to smoking time users tend to swallow some of the cigarettes juices. Public health advocates worry that laws 28 Snuff is finely ground tobacco that banning smoking in certain public places will comes in dry or moist forms and is Number of cancer causing not effectively encourage people to quit sometimes packaged in ready-to-use agents in smokeless tobacco. using tobacco products as long as snus is pouches. Dry snuff is usually sniffed or available. swallowed, whereas moist snuff— similar to snus (see below)—is placed Dissolvable tobacco is powdered $354 million between the gum and the lip or cheek tobacco that is compressed to resemble a and slowly absorbed.